Glyset and Nausea and vomiting - a phase IV clinical study of FDA data
Nausea and vomiting is found among people who take Glyset, especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Glyset and have Nausea and vomiting. It is created by eHealthMe based on reports of 349 people who have side effects when taking Glyset from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
349 people reported to have side effects when taking Glyset.
Among them, 19 people (5.44%) have Nausea and vomiting.
What is Glyset?
Glyset has active ingredients of miglitol. eHealthMe is studying from 353 Glyset users for its effectiveness, alternative drugs and more.
What is Nausea and vomiting?
Nausea and vomiting is found to be associated with 4,867 drugs and 5,536 conditions by eHealthMe.
Number of Glyset and Nausea and vomiting reports submitted per year:
Time on Glyset when people have Nausea and vomiting *:
Gender of people who have Nausea and vomiting when taking Glyset*:
Age of people who have Nausea and vomiting when taking Glyset *:
Common drugs people take besides Glyset *:
Common side effects people have besides Nausea and vomiting *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Glyset and have Nausea and vomiting?Check whether Nausea and vomiting is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
How severe was Nausea and vomiting and when was it recovered:
Expand to all the drugs that have ingredients of miglitol:
Alternative drugs to, pros and cons of Glyset:
- Glyset (353 reports)
Nausea and vomiting treatments and more:
- Nausea and vomiting (460,779 reports)
COVID vaccines that are related to Nausea and vomiting:
- Nausea and vomiting in Moderna COVID Vaccine
- Nausea and vomiting in Pfizer BioNTech Covid Vaccine
- Nausea and vomiting in Johnson and Johnson Covid Vaccine
Common drugs associated with Nausea and vomiting:
- Prednisone: 21,089 reports
- Metformin: 17,857 reports
- Methotrexate: 17,472 reports
- Aspirin: 17,199 reports
- Humira: 15,798 reports
- Omeprazole: 14,792 reports
- Lisinopril: 10,667 reports
- Ibuprofen: 10,601 reports
- Pantoprazole: 10,552 reports
- Enbrel: 10,295 reports
All the drugs that are associated with Nausea and vomiting:
- Nausea and vomiting (4,867 drugs)
Common conditions associated with Nausea and vomiting:
- Rheumatoid arthritis: 19,306 reports
- High blood pressure: 17,832 reports
- Pain: 17,500 reports
- Multiple sclerosis: 16,606 reports
All the conditions that are associated with Nausea and vomiting:
- Nausea and vomiting (5,536 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on miglitol (the active ingredients of Glyset) and Glyset (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Crestor and Mydriasis - now
- Cyanocobalamin and Breath Sounds - 7 seconds ago
- Copaxone and T-Cell Lymphoma - 7 seconds ago
- Cosentyx and Amoebiasis - 9 seconds ago
- Lariam and Urination - Excessive At Night - 10 seconds ago
- Cresemba and Seizures - 16 seconds ago
- Sublimaze and Malignant Neoplasm Progression - 17 seconds ago
- Plegridy and Marijuana drug interaction - 17 seconds ago
- Risedronate Sodium and Azilect drug interaction - 21 seconds ago
- Crestor and Urinary Bladder Haemorrhage - 23 seconds ago